BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11380392)

  • 1. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
    de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
    Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for spontaneous interleukin-8 production by acute myeloid leukemic cells in angiogenesis related processes: work in progress.
    de Bont ES; Vellenga E; Molema G; van Wering E; de Leij LF; Kamps WA
    Med Pediatr Oncol; 2001 Dec; 37(6):511-7. PubMed ID: 11745889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
    Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
    Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
    Xu D; Meng FY; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of increased angiogenesis in patients with acute myeloid leukemia.
    Hussong JW; Rodgers GM; Shami PJ
    Blood; 2000 Jan; 95(1):309-13. PubMed ID: 10607717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo.
    Schuch G; Machluf M; Bartsch G; Nomi M; Richard H; Atala A; Soker S
    Blood; 2002 Dec; 100(13):4622-8. PubMed ID: 12453880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
    Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
    Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
    Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
    Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of endothelial cell-associated molecules in AML cells.
    Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth.
    Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y
    Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts.
    Kasama T; Shiozawa F; Kobayashi K; Yajima N; Hanyuda M; Takeuchi HT; Mori Y; Negishi M; Ide H; Adachi M
    Arthritis Rheum; 2001 Nov; 44(11):2512-24. PubMed ID: 11710707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic cytokines. Quantitative and functional analysis.
    Eggert A; Maris JH
    Methods Mol Biol; 2003; 215():117-33. PubMed ID: 12512294
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
    Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.